Literature DB >> 18480197

The aprotinin story--is BART the final chapter?

Wayne A Ray, C Michael Stein.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18480197     DOI： 10.1056/NEJMe0803514

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  8 in total

1.  A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009.

Authors:  Peter G M Mol; Sabine M J M Straus; Sigrid Piening; Jonie T N de Vries; Pieter A de Graeff; Flora M Haaijer-Ruskamp
Journal:  Drug Saf       Date:  2010-06-01       Impact factor: 5.606

Review 2.  Coagulation abnormalities in the trauma patient: the role of point-of-care thromboelastography.

Authors:  Eduardo Gonzalez; Fredric M Pieracci; Ernest E Moore; Jeffry L Kashuk
Journal:  Semin Thromb Hemost       Date:  2010-10-26       Impact factor: 4.180

3.  Perioperative safety of aprotinin in coronary artery bypass graft surgery: is there life after BART?

Authors:  John G Augoustides
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

Review 4.  The safety of aprotinin and lysine-derived antifibrinolytic drugs in cardiac surgery: a meta-analysis.

Authors:  David Henry; Paul Carless; Dean Fergusson; Andreas Laupacis
Journal:  CMAJ       Date:  2008-12-02       Impact factor: 8.262

Review 5.  Methods to decrease blood loss and transfusion requirements for liver transplantation.

Authors:  Kurinchi Selvan Gurusamy; Theodora Pissanou; Hynek Pikhart; Jessica Vaughan; Andrew K Burroughs; Brian R Davidson
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

6.  Impact of aprotinin and renal function on mortality: a retrospective single center analysis.

Authors:  Brian Schloss; Parul Gulati; Lianbo Yu; Mahmoud Abdel-Rasoul; William O'Brien; Jon Von Visger; Hamdy Awad
Journal:  J Cardiothorac Surg       Date:  2011-08-30       Impact factor: 1.637

7.  Aprotinin and classic wound drainage are unnecessary in total hip replacement - a prospective randomized trial.

Authors:  F Fleischmann; C Matuschek; K Orth; P A Gerber; R Mota; W T Knoefel; M Peiper; M Schick; M van Griensven; Edwin Bölke; W Fleischmann
Journal:  Eur J Med Res       Date:  2011-01-27       Impact factor: 2.175

8.  The aprotinin saga and the risks of conducting meta-analyses on small randomised controlled trials - a critique of a Cochrane review.

Authors:  Måns Rosén
Journal:  BMC Health Serv Res       Date:  2009-02-19       Impact factor: 2.655
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.